Kevin D. Freeman, Director at Galectin Therapeutics, holds 132.83K shares in Galectin Therapeutics (Ticker: GALT). Most recently, Kevin D. Freeman Bought $1,300 shares of Galectin Therapeutics on Oct 17, 2024 for an estimated value of 3.43K.
What is the percentage of profitable transactions made by Kevin D. Freeman?
The percentage of profitable transactions made by Kevin D. Freeman is 41%.
What is the average return per transaction made by Kevin D. Freeman?
The average return per transaction made by Kevin D. Freeman is -11.00%.
What stocks does Kevin D. Freeman hold?
Kevin D. Freeman holds: GALT stocks.
What was Kevin D. Freeman’s latest transaction?
Kevin D. Freeman latest transaction was an Informative Buy of $3.43K.
What was Kevin D. Freeman's most profitable transaction?
Kevin D. Freeman’s most profitable transaction was an Informative Buy of GALT stock on December 8, 2017. The return on the trade was 104.50%.
What is Kevin D. Freeman's role in Galectin Therapeutics?
Kevin D. Freeman's role in Galectin Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.